Montelukast Prescribing at BROWNLOW GROUP PRACTICE
Cromoglycate, leukotriene and phosphodesterase type-4 inhib | Respiratory System
Items (12m)
3,015
Total Quantity
47.1K
NHS Cost
£2.8K
vs National Avg
+340.3%
BROWNLOW GROUP PRACTICE prescribed 3,015 items of Montelukast over the last 12 months at a cost of £2,792 to the NHS. This is 340.3% above the national average prescribing rate. Montelukast is classified under Cromoglycate, leukotriene and phosphodesterase type-4 inhib in the BNF.
Monthly Prescribing Trend
Jun 2026
243
Jun 2026
236
Jun 2026
291
Jun 2026
223
Jun 2026
239
Jun 2026
249
Jun 2026
253
Jun 2026
279
Jun 2026
269
Jun 2026
240
Jun 2026
250
Jun 2026
243
Prescribing Details
| Total Items | 3,015 |
|---|---|
| Total Quantity | 47,136 |
| Total NHS Cost | £2,792 |
| Presentations | 4 different forms |
| vs National Average | +340.3% |
Montelukast Prescribing Comparison
| This practice | 3,015 items |
|---|---|
| National average per practice | 685 items |
| Difference | +340.3% vs national average |
Explore More
Data sourced from NHSBSA English Prescribing Dataset, CQC, and GP Patient Survey. Prescribing data does not indicate quality of care. Higher prescribing rates may reflect patient demographics. Always consult your GP for medical advice.